FDA criticised for rejecting over the counter emergency contraception
Nieuws van: British Medical Journal
The US Food and Drug Administration's decision to refuse to approve over the counter status for the emergency contraceptive Plan B (levonorgestrel) was flawed, unusual, and not standard FDA procedure. This is finding of a report by the Government Accountability Office, an independent investigative agency of the US Congress.
http://bmj.bmjjournals.com/cgi/content/extract/331/7527/1223-a - 26 Nov 2005
|
Printen
Doorsturen